Crism Therapeutics (LSE:CRTX) Accounts Payable : £0.15 Mil (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Accounts Payable?

Crism Therapeutics's Accounts Payable for the quarter that ended in Jun. 2024 was £0.15 Mil.

Crism Therapeutics's quarterly Accounts Payable increased from Jun. 2023 (£0.30 Mil) to Dec. 2023 (£0.37 Mil) but then declined from Dec. 2023 (£0.37 Mil) to Jun. 2024 (£0.15 Mil).

Crism Therapeutics's annual Accounts Payable increased from Dec. 2021 (£0.08 Mil) to Dec. 2022 (£0.11 Mil) and increased from Dec. 2022 (£0.11 Mil) to Dec. 2023 (£0.37 Mil).

Crism Therapeutics Accounts Payable Historical Data

The historical data trend for Crism Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Accounts Payable Chart

Crism Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.27

0.23

0.08

0.11

0.37

Crism Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable	Get a 7-Day Free Trial															0.16	0.11	0.30	0.37	0.15

Crism Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Crism Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB

Website

https://www.crismtherapeutics.com

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines